Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | DPP4 | P27487 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26111413 | 0.76 | — | — | |
| SCHEMBL26522338 | 0.69 | L3MBTL1 (0.39) | TDP1L3MBTL1MEN1KMT2ADPP4 | |
| SCHEMBL30598376 | 0.68 | RAB9A (0.39) | TDP1SMN1; SMN2 | |
| SCHEMBL26112607 | 0.67 | RAB9A (0.38) | TDP1SMN1; SMN2 | |
| SCHEMBL26114042 | 0.65 | — | — | |
| SCHEMBL22870282 | 0.64 | DPP4 (0.41) | TDP1L3MBTL1MEN1KMT2ADPP4 | |
| SCHEMBL5837395 | 0.63 | SMN1; SMN2 (0.51) | TDP1L3MBTL1SMN1; SMN2 | |
| SCHEMBL2899285 | 0.62 | MEN1 (0.33) | MEN1KMT2A | |
| SCHEMBL22624008 | 0.62 | — | — | |
| SCHEMBL20391368 | 0.61 | DPP4 (0.49) | DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023187012-A1 | COMPOSITIONS INCLUDING AQUEOUS AMINE BORANE COMPLEXES AND POLYNUCLEOTIDES, AND METHODS OF USING THE SAME TO DETECT METHYLCYTOSINE OR HYDROXYMETHYLCYTOSINE | ILLUMINA CAMBRIDGE LIMITED (GB) | 2023-10-05 | — | — | WO | disclosed |